Status:

RECRUITING

PPI Supplementation to Fight ECtopIc Calcification in PXE

Lead Sponsor:

Centre Hospitalier Universitaire de Nice

Conditions:

Pseudoxanthoma Elasticum

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Pseudoxanthoma elasticum (PXE) is a rare inherited metabolic disorder (OMIM 264800, frequency 1/25000) characterized by progressive ectopic calcification of connective tissues. PXE mainly affects the ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients (\>18 years and \<65 years), men and women, presenting a clinically and biologically authenticated PXE (genotype + phenotype) according to the international diagnostic criteria (26).
  • Efficient contraceptive method in woman of childbearing age at inclusion and during the overall study
  • Patient affiliated to a social security insurance
  • Signed informed consent
  • Patient without acute complication linked or not to the pathology at the time of the study
  • NON-INCLUSION CRITERIA
  • Renal insufficiency (i.e. defined by a renal clearance \<30ml / min / 1.73 m²)
  • Patients with osteomalacia
  • Patients with chronic diarrhea (\> 1 month)
  • Pregnancy, lactating or fertile women who may wish to become pregnant within three years.
  • Any other medical condition that may be considered in the opinion of the Principal Investigator.
  • Use of bisphosphonate during last 5 years.
  • Hypocalcemia (calcium \<2.20 mmol/L and ionized calcium \<1.15 mmol/L) \*.
  • Vitamin D deficiency \<35 nmol/L \*
  • Enrollment in another inteventional clinical trial which could interfere with the present study
  • patients (\>18 years) protected by law
  • After correcting the hypocalcemia and/or vitamin D deficiency, a participant is again suitable for participation in the trial, as long as the participant meets the inclusion criteria.

Exclusion

    Key Trial Info

    Start Date :

    December 13 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2027

    Estimated Enrollment :

    99 Patients enrolled

    Trial Details

    Trial ID

    NCT04868578

    Start Date

    December 13 2022

    End Date

    September 1 2027

    Last Update

    May 17 2024

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Angers Hospital

    Angers, France, 49000

    2

    Nice Hospital

    Nice, France, 06000

    PPI Supplementation to Fight ECtopIc Calcification in PXE | DecenTrialz